DennisHLangerMDJD

Child & Adolescent Psychiatry

Board of Directors/Founder, Biopharmaceutical Companies.; Board of Directors, Braeburn, Inc.; Board of Directors, Whitehead Institute for Biomedical Research; former Clinical Professor, Psychiatry, Georgetown University School of Medicine; former Senior Vice President, Research and Development, GlaxoSmithKline

Join to view full profile

Dr. Langer is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Langer's full profile

Already have an account?

Office
8231 Bay Colony Dr
#1804
Naples, FL 34108

Education & Training

Harvard Law SchoolJ.D., Law, cum laude, 1980 - 1983
Boston Children’s HospitalFellowship, Child and Adolescent Psychiatry, 1980 - 1982
National Capital ConsortiumFellowship, Child and Adolescent Psychiatry, 1978 - 1980
Yale-New Haven Medical CenterResidency, Psychiatry, 1976 - 1978
Yale-New Haven Medical CenterInternship, Internal Medicine, 1975 - 1976
Georgetown University School of MedicineClass of 1975
Columbia UniversityBA, Biology, 1969 - 1971

Certifications & Licensure

FL State Medical License 2009 - 2026
PA State Medical License 1992 - 2026
NJ State Medical License 1994 - 2025
IL State Medical License 1985 - 2017
MD State Medical License 1978 - 1982
American Board of Psychiatry and Neurology Psychiatry

Publications & Presentations

PubMed

149 citations
Valproic acid hepatic fatalities. II. US experience since 1984.
Fritz E. Dreifuss, Dennis H. Langer, Karen A. Moline, Jim E. Maxwell
Neurology. 1989-02-01
349 citations
Valproic acid hepatic fatalities: a retrospective review
Fritz E. Dreifuss, N. Santilli, Dennis H. Langer, K. P. Sweeney, K. A. Moline
Neurology. 1987-03-01
20 citations
Evidence of lack of abuse or dependence following pemoline treatment: Results of a retrospective survey
Dennis H. Langer, Kevin P. Sweeney, David E. Bartenbach, Patricia M. Davis, Kerstin B. Menander
Drug and Alcohol Dependence. 1986-06-01

Press Mentions

Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF), Innovation, Partnerships, and Leadership: A 2021 OutlookSeptember 13th, 2021
Vertex Taps Longtime Commercial Lead to Fill Two-Year COO Vacancy; Nancy Thornberry Set for Different Role at Kallyope with an Old Friend from Merck Waiting in the WingsAugust 6th, 2021

Committees

Board of Directors, Whitehead Institute for Biomedical Research 2020 - Present
Member, Dean's Advisory Board, Harvard Law School 2010 - Present
Member, Committee on Medical Center Affairs, Board of Directors, Georgetown University 2007 - 2012
Chair, Committee on Medical Center Affairs, Board of Regents, Georgetown University 2006 - 2010
Vice Chair, Board of Visitors, Columbia College 2005 - 2008

Industry Relationships

Director, Creyon Bio, Inc.2021 - Present
Director, Empirico, Inc.2021 - Present
Director, Quoin Pharmaceuticals, Inc. (Nasdaq:QNRX)2021 - Present
Board of Directors, Braeburn, Inc.2015 - Present
Vice Chair, Board of Directors, EnGene, Inc.2015 - 2023
Board of Directors, Myriad Genetics, Inc. (Nasdaq:MYGN)2004 - 2022
Board of Directors, Dicerna Pharmaceuticals, Inc. (Nasdaq:DRNA)2007 - 2019